News Archive

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, announced today that the US Food and Drug Administration (FDA) granted marketing authorization to GlaxoSmithKline’s (GSK) herpes zoster vaccine, SHINGRIX, containing Agenus’ proprietary immune adjuvant QS-21 Stimulon®. SHINGRIX is indicated for prevention of herpes zoster (also known as shingles) in adults aged 50 years and older. The addition of QS-21 Stimulon helps improve the vaccine’s effectiveness by boosting immune response in older adults who often experience age-related decline in immunity.   

Gov. Larry Hogan is supporting Elon Musk and his desire to bring an undergrond hyperloop to the East Coast, and it seems like a bit of the Tesla founder’s social media strategy has rubbed off on the Maryland Republican.

The Kauffman Index of Entrepreneurship series offers in-depth measures of the people and businesses that contribute to America’s overall economic dynamism.

Join Maryland Tech Council CEO, Tami Howie, at the 7th Annual TEDCO’s Entrepreneur Expo on October 25, 2017 for a fireside chat with Mike Heslin, the Baltimore Market Manager for Lyft from 4:00 PM – 5:00 PM in Room Key 12.

AstraZeneca and MedImmune, our global biologics research and development arm, have been voted one of the top science employers worldwide, in the prestigious Science 2017 Top Employers Survey1.

Our key strengths, as highlighted by survey participants, focused on our aspirational work culture, our dynamic and intellectually challenging environment, and our commitment to collaboration, which our scientists enjoy at research centres across the globe. 

Many are exploring alternatives to traditional ‘per pill’ arrangements underlying reimbursement. This holds implications for pharma manufacturers.

OCTOBER 26, 2017

Host:  UM BioPark & Wexford Science + Technology

Location:  UM BioPark Life Sciences Conference Centeer 801 W. Baltimore Street Baltimore  Maryland  21201

Time:  5:00pm to 6:30pm

Please join the BioPark’s Monthly Networking Event. Mingle with BioPark tenants, and UMB faculty and staff.

Thursday, December 07, 2017 5:30 PM – 7:30 PM EST

Horseshoe Casino Baltimore 1525 Russell Street Baltimore, MD 21230

We’re excited to announce MTC’s first annual Black & White Affair. Our exclusive holiday party will feature gourmet appetizers, music, unique silent auction items and cocktails as you help fund internships through the inMD platform.

Since the launch of the BioPark Initiative in 2003, the BioPark has grown to include nearly three dozen companies with more than 1,000 employees. Looking out a fifth-floor window of BioPark Building One, BioPark Senior Vice President Jane Shaab pointed out other BioPark facilities, such as the Maryland Proton Treatment Center, the Maryland Forensic Medical Center, the newly added Lion Brothers Building, and the construction site where work has begun on BioPark Building Three, a facility that will double the number of BioPark employees.

The Food and Drug Administration on Wednesday approved the second in a radically new class of treatments that genetically reboot a patient’s own immune cells to kill cancer.